Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy.

Source:http://linkedlifedata.com/resource/pubmed/id/18083897

Download in:

View as

General Info

PMID
18083897